Church & Dwight Co., Inc. (NYSE:CHD) Stock Holdings Increased by Concurrent Investment Advisors LLC

Concurrent Investment Advisors LLC grew its holdings in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 6.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,264 shares of the company’s stock after purchasing an additional 184 shares during the period. Concurrent Investment Advisors LLC’s holdings in Church & Dwight were worth $342,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Holocene Advisors LP bought a new stake in shares of Church & Dwight during the third quarter valued at about $104,795,000. State Street Corp boosted its holdings in shares of Church & Dwight by 8.0% in the third quarter. State Street Corp now owns 13,116,334 shares of the company’s stock worth $1,373,542,000 after buying an additional 969,006 shares during the period. World Investment Advisors LLC purchased a new position in Church & Dwight during the 3rd quarter worth approximately $58,338,000. Barclays PLC grew its holdings in shares of Church & Dwight by 63.9% during the third quarter. Barclays PLC now owns 1,106,131 shares of the company’s stock valued at $115,832,000 after buying an additional 431,257 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its holdings in shares of Church & Dwight by 5.7% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 8,016,345 shares of the company’s stock valued at $839,472,000 after purchasing an additional 429,863 shares during the period. Institutional investors and hedge funds own 86.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. JPMorgan Chase & Co. dropped their target price on Church & Dwight from $107.00 to $106.00 and set an “underweight” rating on the stock in a research report on Friday, February 21st. Piper Sandler cut their target price on shares of Church & Dwight from $128.00 to $126.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. TD Cowen increased their price objective on Church & Dwight from $114.00 to $117.00 and gave the company a “buy” rating in a research report on Monday, November 4th. Truist Financial lifted their target price on Church & Dwight from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, February 3rd. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of Church & Dwight from $114.00 to $115.00 and gave the company a “buy” rating in a report on Monday, November 4th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $111.47.

Church & Dwight Stock Up 2.8 %

Shares of CHD opened at $110.56 on Wednesday. The firm’s 50 day moving average is $105.48 and its 200-day moving average is $104.84. Church & Dwight Co., Inc. has a 12 month low of $96.35 and a 12 month high of $113.50. The company has a current ratio of 1.70, a quick ratio of 1.24 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $27.19 billion, a PE ratio of 46.65, a P/E/G ratio of 3.32 and a beta of 0.59.

Church & Dwight (NYSE:CHD) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.77 EPS for the quarter, hitting analysts’ consensus estimates of $0.77. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. During the same quarter in the previous year, the company posted $0.65 earnings per share. Equities research analysts forecast that Church & Dwight Co., Inc. will post 3.7 EPS for the current year.

Church & Dwight Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Friday, February 14th will be paid a $0.295 dividend. This is a boost from Church & Dwight’s previous quarterly dividend of $0.28. The ex-dividend date is Friday, February 14th. This represents a $1.18 annualized dividend and a dividend yield of 1.07%. Church & Dwight’s payout ratio is currently 49.79%.

Insider Buying and Selling at Church & Dwight

In related news, EVP Rick Spann sold 39,520 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $112.00, for a total transaction of $4,426,240.00. Following the completion of the sale, the executive vice president now owns 4,973 shares of the company’s stock, valued at $556,976. This trade represents a 88.82 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Michael Read purchased 1,100 shares of Church & Dwight stock in a transaction on Monday, December 16th. The stock was bought at an average price of $106.82 per share, with a total value of $117,502.00. Following the completion of the acquisition, the executive vice president now directly owns 2,505 shares of the company’s stock, valued at approximately $267,584.10. This trade represents a 78.29 % increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have sold 49,522 shares of company stock worth $5,487,555. Insiders own 2.00% of the company’s stock.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.